Evaluation StudiesEvaluation Studies as TopicHealth Information SystemsInformaticsResearch ReportTreatment OutcomeCatheterization, Swan-GanzMineralocorticoid Receptor AntagonistsSpironolactoneDay CareProgram EvaluationPositron-Emission TomographyFluorodeoxyglucose F18Information SystemsBenzenesulfonatesAntineoplastic AgentsTomography, X-Ray ComputedVisual Field TestsPhenylurea CompoundsAntineoplastic Combined Chemotherapy ProtocolsNiacinamideChemoembolization, TherapeuticRadiopharmaceuticalsPilot ProjectsGermanyReproducibility of ResultsSensitivity and SpecificityDisease-Free SurvivalRandomized Controlled Trials as TopicProspective StudiesDecision Support TechniquesFollow-Up StudiesNetherlandsHeart FailureLiver NeoplasmsNeoplasm MetastasisPredictive Value of TestsData CollectionQuestionnairesDrug Administration ScheduleResearch DesignCost-Benefit AnalysisTime FactorsSurvival AnalysisNeoadjuvant TherapySelf CareYttrium RadioisotopesInterviews as TopicTumor BurdenDisease ProgressionHealth PromotionNeoplasm StagingPyrrolesMaximum Tolerated DoseQuinazolinesAntibodies, Monoclonal, HumanizedUnited StatesLung NeoplasmsCarcinoma, Renal CellRisk FactorsBridged CompoundsKidney NeoplasmsGastrointestinal Stromal TumorsSurvival RateDeoxycytidineNeoplasmsMultimodal ImagingSarcomaDiagnostic ImagingAngiogenesis InhibitorsTaxoidsKaplan-Meier EstimateCross-Sectional StudiesCarcinoma, HepatocellularPrognosisPyrimidinesIndolesCarcinoma, Non-Small-Cell LungRetrospective StudiesProtein Kinase InhibitorsFluorouracilEpothilonesNeuroendocrine TumorsPyridinesBenzamidesColorectal NeoplasmsAlgorithmsNeoplasm Recurrence, LocalPleural NeoplasmsMelanomaClinical Trials, Phase II as TopicOrganoplatinum CompoundsPiperazinesCombined Modality TherapyChemotherapy, AdjuvantPeritoneal NeoplasmsContrast MediaDrug Resistance, NeoplasmAntibodies, MonoclonalClinical Trials as Topic